Weighted Average Number of Shares Outstanding, Diluted of Vitro Biopharma, Inc. from 31 Jul 2010 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Vitro Biopharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Jul 2010 to 31 Jan 2026.
  • Vitro Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Jan 2026 was 4,477,297, a 0.38% increase year-over-year.
  • Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 4,460,535, a 0.03% increase from 2024.
  • Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 4,459,224, a 0.65% increase from 2023.
  • Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4,430,535, a 6.9% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 4,477,297 +16,762 +0.38% 01 Nov 2025 31 Jan 2026 10-Q 16 Mar 2026 2026 Q1
Q3 2025 4,460,535 +1,311 +0.03% 01 Aug 2025 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q2 2025 4,460,535 0 0% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q3
Q1 2025 4,460,535 0 0% 01 Feb 2025 30 Apr 2025 10-Q 20 Jun 2025 2025 Q2
Q4 2024 4,460,535 +5,217 +0.12% 01 Nov 2024 31 Jan 2025 10-Q 16 Mar 2026 2026 Q1
Q3 2024 4,459,224 +28,689 +0.65% 01 Aug 2024 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q2 2024 4,460,535 +30,000 +0.68% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q3
Q1 2024 4,460,535 +30,000 +0.68% 01 Feb 2024 30 Apr 2024 10-Q 20 Jun 2025 2025 Q2
Q4 2023 4,455,318 +24,783 +0.56% 01 Nov 2023 31 Jan 2024 10-Q 20 Mar 2025 2025 Q1
Q3 2023 4,430,535 01 Aug 2023 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q2 2023 4,430,535 -10 0% 01 May 2023 31 Jul 2023 10-Q 16 Sep 2024 2024 Q3
Q1 2023 4,430,535 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024 2024 Q2
Q4 2022 4,430,535 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q2 2022 4,430,545 01 May 2022 31 Jul 2022 10-Q 28 Aug 2023 2023 Q3
Q4 2014 19,971,822 +168,419 +0.85% 01 Nov 2014 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q1 2014 19,840,856 +325,974 +1.7% 01 Feb 2014 30 Apr 2014 10-Q 19 Jun 2014 2014 Q2
Q4 2013 19,803,403 01 Nov 2013 31 Jan 2014 10-Q 24 Mar 2015 2015 Q1
Q1 2013 19,514,882 +643,665 +3.4% 01 Feb 2013 30 Apr 2013 10-Q 19 Jun 2014 2014 Q2
Q3 2012 18,993,351 +539,699 +2.9% 01 Aug 2012 31 Oct 2012 10-K 12 Feb 2014 2013 FY
Q2 2012 19,260,814 +741,160 +4% 01 May 2012 31 Jul 2012 10-Q/A 17 Oct 2012 2012 Q3
Q1 2012 18,871,217 +421,550 +2.3% 01 Feb 2012 30 Apr 2012 10-Q/A 22 Jun 2012 2012 Q2
Q4 2011 18,528,995 +149,010 +0.81% 01 Nov 2011 31 Jan 2012 10-Q 21 Mar 2012 2012 Q1
Q3 2011 18,453,652 01 Aug 2011 31 Oct 2011 10-K/A 16 Feb 2012 2011 FY
Q2 2011 18,519,654 +570,384 +3.2% 01 May 2011 31 Jul 2011 10-Q/A 17 Oct 2012 2012 Q3
Q1 2011 18,449,667 01 Feb 2011 30 Apr 2011 10-Q/A 22 Jun 2012 2012 Q2
Q4 2010 18,379,985 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012 2012 Q1
Q2 2010 17,949,270 01 May 2010 31 Jul 2010 10-Q/A 12 Oct 2011 2011 Q3

Vitro Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 4,460,535 +1,311 +0.03% 01 Nov 2024 31 Oct 2025 10-K 13 Feb 2026 2025 FY
2024 4,459,224 +28,689 +0.65% 01 Nov 2023 31 Oct 2024 10-K 13 Feb 2026 2025 FY
2023 4,430,535 +286,413 +6.9% 01 Nov 2022 31 Oct 2023 10-K 28 Jan 2025 2024 FY
2022 4,144,122 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
2014 19,881,321 +291,882 +1.5% 01 Nov 2013 31 Oct 2014 10-K 13 Feb 2015 2014 FY
2013 19,589,439 +596,088 +3.1% 01 Nov 2012 31 Oct 2013 10-K 13 Feb 2015 2014 FY
2012 18,993,351 +539,699 +2.9% 01 Nov 2011 31 Oct 2012 10-K 12 Feb 2014 2013 FY
2011 18,453,652 +583,728 +3.3% 01 Nov 2010 31 Oct 2011 10-K/A 16 Feb 2012 2011 FY
2010 17,869,924 01 Nov 2009 31 Oct 2010 10-K/A 16 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.